BnR Summit 2026

Belt & Road Summit - Deal-Making 2026

9 – 15 Sept 2026 | Hong Kong, China (Hong Kong)

Investment TargetUpdated on 1 September 2026

Drug delivery system

CEO Office Director at CF PharmTech, Inc. 长风药业股份有限公司

China (Hong Kong)

About

RNA Delivery Technologies

We are seeking partners and technology providers advancing next-generation delivery platforms for RNA therapeutics — including alternatives and improvements to conventional lipid nanoparticles (LNPs), such as polymer-based carriers, extracellular vesicles, ligand-conjugate systems, and next-generation ionizable lipids targeting extra-hepatic tissues. We are particularly interested in platforms that improve payload capacity, tissue selectivity, manufacturability, and repeat-dose tolerability relative to first-generation systems. We welcome conversations with delivery-technology developers, platform companies, and academic or industry researchers holding validated or emerging IP relevant to mRNA, siRNA, ASO, or circular RNA delivery, with a view toward licensing, co-development, or sponsored research collaboration. Deal structures are open to negotiation depending on stage of development and IP position.

Looking for

  • Public–private partnership / Concession
  • Requisition of Service

Similar opportunities